Exam 2 Drugs Flashcards
Phenoxybenzamine
Noncompetitive (meaning it will have a slow on set of action)
Administered orally
Irreversible antagonist b/c it has an active metabolite that forms a covalent bond
Decreases vascular resistance?
Decrease supine and BP?
Treats hypertension patients w/ pheochromocytoma (a tumor of the adrenal medulla that secretes huge amount of catecholamines)
Also used during surgery to control hypertension
Phentolamine
Competitive (immediate on set of action)
Administered intravenously = produces vasodilation (opens up the vessels) decreasing BP
Reversible antagonist
Treats acute hypertension by the alpha agonist
used to counter act localized ischemia (inadequate blood supply to an organ)
Increase HR block alpha 2 receptor
Prazosin
Selective alpha 1 antagonist
Calcium Channel Blocker
Relaxes the vascular and other SM (urethra, urinary bladder, and prostate)
Produces vasodilation (expands vessels) = decrease BP
Treat primary hypertension
Doesn’t increase HR it doesnt block alpha 2 receptor
Causes less tachycardia than phentolamine
Doxazosin
Selective alpha 1 antagonist
Treats lower urinary tract symptoms associated with benign prostatic (prostate alpha 1) hyperplasia
Drug blocks alpha 1 receptor on prostate which allow SM to relax and allows urination
Terazosin
Selective alpha 1 antagonist
Alfuzosin
Selective alpha 1 antagonist
Treats lower urinary tract symptoms associated with benign prostatic hyperplasia
Drug blocks alpha 1 receptor on prostate which allow SM to relax and allows urination
Tamsulosin
Selective alpha 1 antagonist
Treats lower urinary tract symptoms associated with benign prostatic hyperplasia
Drug blocks alpha 1 receptor on prostate which allow SM to relax and allows urination
Siiodosin
Selective alpha 1 antagonist
Nadolol
Beta nonselective antagonist
inhibits renin secretion?
Pinodolol
Beta nonselective antagonist
Inhibits renin secretion?
Propranolol
Beta 1 nonselective antagonist (block beta 1 and 2)
Administered orally or parentally
used for hypertension, cardiac dysrhythmias, migraines, and angina pectoris
Decrease HR and cardiac output
Timolol
Beta 1 nonselective antagonist (block beta 1 and 2)
Administered as an eye drop for glaucoma
Carteolol
Beta nonselective antagonist
Inhibits renin secretion?
Pilocarpine
Muscarinic receptor agonists (helps flow)
Site of action is the trabecular meshwork
Stimulates the contraction of meridional ciliary muscle fibers (the eye)
Atenolol
Selective beta 1 blocker (block beta 2)
Block beta 2 receptors in the lungs, liver, and vascular SM to avoid beta 2 adverse effects (bronchoconstriction, hypoglycemia, decrease in peripheral blood flow)
Treat hypertension, angina pectoris, and acute myocardial infarction
Decrease HR and cardiac output
Metroprolol
Selective beta 1 blocker (block beta 2)
Block beta 2 receptors in the lungs, liver, and vascular SM to avoid beta 2 adverse effects (bronchoconstriction, hypoglycemia, decrease in peripheral blood flow)
Treat hypertension, angina pectoris, and acute myocardial infarction
Decrease HR and cardiac output
Esmolol
Selective beta 1 blocker
Administered parentally
Decrease HR and cardiac output
Carvedilol
Beta 3 nonselective antagonists (block alpha 1, beta 1 and 2)
Calcium Channel Blocker
Administered orally
Reduce ventricular wall tension and oxygen demand
Labetalol
Beta 3 nonselective antagonists (block alpha 1, beta 1, and 2)
Administered orally
Verapamil
Direct acting vasodilators
Calcium channel blocker use for SM and heart
Affect cardio myocytes
Target both vascular and cardiac tissue, reduce HR and cardiac output
Reduces ventricular wall tension and oxygen demand
Decrease afterload
Reduces digoxin clearance and increases serum digoxin levels by inhibiting P-glycoprotein mediated renal excretion
Diltiazem
Direct acting vasodilators
Calcium channel blocker use for SM and heart
Affect cardio myocytes
Target both vascular and cardiac tissue, reduce HR and cardiac output
Reduces ventricular wall tension and oxygen demand
Decrease afterload
Reduces digoxin clearance
Increases serum digoxin levels by inhibiting P-glycoprotein mediated renal excretion
Hydralazine
Direct acting vasodilators
CCB
Inhibits IP3 induced calcium release from the sarcoplasmic reticulum
Favors relaxation
Decreases BP
Increases HR, SV, and CO
Dilate arterioles NOT veins (affects after load)
Reduces ventricular wall tension and oxygen demand
LosarTAN
Angiotensin 2 receptor antagonist
Block angiotensin 2 in SM and adrenal medulla
ValsarTAN
Angiotensin 2 receptor antagonist
Block angiotensin 2 in SM and adrenal medulla
CandesarTAN
Angiotensin receptor antagonist
Block angiotensin 2 in SM and adrenal medulla